• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Globus Medical Inc.

    5/29/25 4:15:11 PM ET
    $GMED
    Medical/Dental Instruments
    Health Care
    Get the next $GMED alert in real time by email
    SD 1 gmed-20250529corresp.htm FORM SD Form SD

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM SD

     

     

    SPECIALIZED DISCLOSURE REPORT

    

     

     

    GLOBUS MEDICAL, INC.

    (Exact name of registrant as specified in charter)

     

     

     

    

     

     

     

     

    DELAWARE

     

    001-35621

     

    04-3744954

    (State or other jurisdiction

    of incorporation or organization)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

    

    2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA 19403

    (Address of principal executive offices) (Zip Code)

    

    KEITH PFEIL

    Executive Vice President, Chief Financial Officer, Chief Operating Officer and Chief Accounting Officer

    (610) 930-1800

    (Name and telephone number, including area code, of the person to contact in connection with this report.)

    

    

    Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

     

    

     

    ☒

    Rule 13p-1 under Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.

    ☐

    Rule 13q-1 under Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended _________.

    

     


     

    Section 1 - Conflict Minerals Disclosure

    

    Item 1.01 Conflict Minerals Disclosure and Report

    

    Globus Medical, Inc. (the “Company”) is filing this Specialized Disclosure Report (“Form SD”), including the Conflict Minerals Report attached as Exhibit 1.01 hereto, for the calendar year ended December 31, 2024 to comply with Rule 13p-1 of the Securities Exchange Act of 1934, as amended. 

    

    A copy of the Company’s Conflict Minerals Disclosure is publicly available at www.investors.globusmedical.com/investors-overview.

    

    Item 1.02 Exhibit

    

    The Company’s Conflict Minerals Report for calendar year 2024 is filed as Exhibit 1.01 to this Form SD and is incorporated herein by reference.

    

    Section 2 – Exhibits

    

    Item 2.01 Exhibits

    

    See the Exhibit Index below, which is incorporated by reference herein.

    

     

     

    EXHIBIT INDEX

    Exhibit No.

     

    Description of Exhibit

    

     

     

    1.01

     

    Conflict Minerals Report of Globus Medical, Inc.

    


     

    SIGNATURES

    

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

    

    

     

     

    

     

    GLOBUS MEDICAL, INC.

    

     

    (Registrant)

    

     

     

    Dated:

    May 29, 2025

    /s/ KEITH PFEIL

    

     

    Keith Pfeil

    

     

    Chief Financial Officer and Chief Operating Officer

    

     

    Chief Accounting Officer

    

     

    Executive Vice President

    

     

    (Principal Financial Officer)

     


    Get the next $GMED alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GMED

    DatePrice TargetRatingAnalyst
    5/27/2025Buy → Neutral
    BTIG Research
    1/10/2025$97.00Underperform → Neutral
    BofA Securities
    12/2/2024$83.00 → $100.00Equal-Weight → Overweight
    Morgan Stanley
    8/7/2024$60.00 → $78.00Equal Weight → Overweight
    Wells Fargo
    5/20/2024$60.00 → $80.00Neutral → Overweight
    Piper Sandler
    3/18/2024$60.00Neutral → Buy
    BTIG Research
    10/20/2023$75.00Buy
    ROTH MKM
    9/19/2023$61.00Hold → Buy
    Stifel
    More analyst ratings